Top Markets
#1 Black Phoenix Black Phoenix +198.52%
#2 Islamic Coin Islamic Coin +158.00%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +45.63%
#5 BasedHype BasedHype +39.57%
#6 Acurast Acurast +23.87%
#7 Cryptopia Cryptopia +21.79%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +21.41%
#9 Moolah Moolah +17.16%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Viropro Inc. Viropro Inc.

Viropro Inc.

VPRO
Classificação em ações #41344
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Preço da ação
$0.00002
Última sincronização: 2026-08-11
Valor de mercado
$25.40K
Variação (1 dia)
0.00%
Variação (1 ano)
-80.00%
País
US
Negociar Viropro Inc. (VPRO)

Categoria

Healthcare
Histórico de preços das ações de Viropro Inc. (VPRO)
Preço de fecho mais alto: $0.00 em 2026-08-01

Preço de fecho mais baixo: $48.56 em 1995-04-01
Histórico de preços das ações da Viropro Inc. de 1995 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.00%
2025 -80.00%
2024 0.00%
2023 0.00%
2022 -57.03%
2021 -55.90%
2020 -27.85%
2019 -52.13%
2018 18.86%
2017 -57.35%
2016 -76.08%
2015 759.65%
2014 -90.11%
2013 126.76%
2012 -82.67%
2011 592.09%
2010 -68.15%
2009 58.59%
2008 -79.14%
2007 -83.61%
2006 0.48%
2005 -14.29%
2004 -13.88%
2003 380.61%
2002 48.03%
2001 -50.58%
2000 -55.16%
1999 -87.89%
1998 -31.96%
1997 -93.03%
1996 -93.27%
1995 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $740.54 8.30%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.48 16.92%
BE